Complications and Clinical Outcomes Following Modified Endoscopic Denker's With Pyriform Aperture Preservation: A Prospective Analysis
Listen to this summary
The authors aimed to evaluate the complication rates and clinical outcomes of the modified endoscopic Denker's approach with pyriform aperture preservation (MEDPAP) for treating maxillary sinus and retromaxillary pathologies. Their prospective study of 52 patients found that while temporary complications such as epiphora and hypesthesia were common, they generally resolved within a few months, and there were no cases of nasal valve collapse or disease recurrence. Overall, MEDPAP demonstrated a 100% success rate in managing benign and select malignant conditions.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from International forum of allergy & rhinology
View all →Jun 9, 2026 · International forum of allergy & rhinology
Translation and Cross-Cultural Adaptation of the Chronic Rhinosinusitis Control Test for Global Use
Jun 1, 2026 · International forum of allergy & rhinology
Assessing Surgical Extent in Endoscopic Sinus Surgery: A Scoping Review of Scoring Systems
May 27, 2026 · International forum of allergy & rhinology
Site-Specific Olfactory Cleft Opacification Predicts Olfactory Function and Olfactory Training Outcome in Persistent Postinfection Olfactory Dysfunction
More in Otolaryngology
View all →Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 22, 2026 · Lancet (London, England)
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
